eric | Shared With: Everyone - Jul 27 2006 | business, research, health, science, investment, NFLD, diabetes
One of my long-shot, single-product, home-run-hopeful stocks presented their product at a conference today and indicated that it has some new benefits which had not been seen before. It may end up being useful in the treatment of diabetes!
Quoted: New Study Explores Use of Novel Form of Northfield's Human Hemoglobin-Based Oxygen Carrier in Pancreatic Islet Cell Transplantation. - EVANSTON, Ill.--(BUSINESS WIRE)--July 27, 2006--Northfield Laboratories Inc. (Nasdaq: NFLD - News) announced today that a preclinical study describing the use of a novel formulation of the Company's human hemoglobin-based oxygen carrier in pancreatic islet cell isolation and transplantation was presented at the World Transplantation Congress in Boston this morning.
Related Content from Around Faves
diabetes
-
Very cool...
3 FaversViewed: 9 TimesQuoted: Rebuilding patients' immune systems from scratch with their own bone marrow stem cells may free type 1 diabetics of the chronic condition
- noreen - Mar 16 20071 FaverViewed: 12 Times
- mohit - Dec 29 20061 FaverViewed: 9 Times
science
-
I don't know, I'm not convinced....
1 FaverViewed: 2 TimesQuoted: The stereotype of computer scientists as geeks who memorize Star Trek lines and never leave the lab may be driving women away from the field, a new study suggests.
- freshmaker13 - 24 days ago1 FaverViewed: 5 Times
- mike - Sep 22 20061 FaverViewed: 30 Times
